PVLA Competitors & Alternatives
Compare Palvella Therapeutics, Inc with similar stocks in the same industry
Biotechnology
PVLA
Main Stock$130.48
Tradestie Score
56
Market Cap
$699.30M
Analyst Upside
+76.7%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.02
|
$2.18B | - | 65 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$14.07
|
$2.08B | - | 53 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$17.24
|
$2.02B | - | 49 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$12.13
|
$2.01B | - | 54 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$31.02
|
$1.97B | - | 52 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$7.02
|
$1.92B | - | 51 | Compare |
|
CELC
Celcuity Inc. Common Stock
|
$72.62
|
$1.92B | - | 45 | Compare |
|
LQDA
Liquidia Corporation Common Stock
|
$28.69
|
$1.90B | 9.2 | 42 | Compare |
|
VERA
Vera Therapeutics, Inc. Class A Common Stock
|
$30.03
|
$1.84B | - | 51 | Compare |
|
IMCR
Immunocore Holdings plc American Depositary Shares
|
$29.56
|
$1.81B | - | 50 | Compare |
More PVLA Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry